Capsida Biotherapeutics Announces Promotion of Rob Murphy to Chief Manufacturing and Quality Officer

Promotion reinforces commitment to advancing our wholly owned gene therapy pipeline and strength of in-house manufacturing capabilities THOUSAND OAKS, Calif., March 12, 2024 /PRNewswire/ — Capsida Biotherapeutics (“Capsida”), a leading fully integrated targeted gene therapy company,…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks